185 related articles for article (PubMed ID: 7251309)
1. Experimental allergic encephalomyelitis. I. Optic nerve and central nervous system manifestations.
Hayreh SS; Massanari RM; Yamada T; Hayreh SM
Invest Ophthalmol Vis Sci; 1981 Aug; 21(2):256-69. PubMed ID: 7251309
[TBL] [Abstract][Full Text] [Related]
2. Experimental allergic encephalomyelitis. II. Retinal and other ocular manifestations.
Hayreh SS
Invest Ophthalmol Vis Sci; 1981 Aug; 21(2):270-81. PubMed ID: 7195894
[TBL] [Abstract][Full Text] [Related]
3. Long-term suppression of neurodegeneration in chronic experimental optic neuritis: antioxidant gene therapy.
Qi X; Sun L; Lewin AS; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2007 Dec; 48(12):5360-70. PubMed ID: 18055782
[TBL] [Abstract][Full Text] [Related]
4. Oligodendrocyte-specific protein is encephalitogenic in rhesus macaques and induces specific demyelination of the optic nerve.
Bajramovic JJ; Brok HP; Ouwerling B; Jagessar SA; van Straalen L; Kondova I; Bauer J; Amor S; 't Hart BA; Ben-Nun A
Eur J Immunol; 2008 May; 38(5):1452-64. PubMed ID: 18412169
[TBL] [Abstract][Full Text] [Related]
5. Optic neuritis and chronic relapsing experimental allergic encephalomyelitis: relationship to clinical course and comparison with multiple sclerosis.
Raine CS; Traugott U; Nussenblatt RB; Stone SH
Lab Invest; 1980 Mar; 42(3):327-35. PubMed ID: 7189001
[TBL] [Abstract][Full Text] [Related]
6. Disruption of the blood-brain barrier in experimental optic neuritis: immunocytochemical co-localization of H2O2 and extravasated serum albumin.
Guy J; McGorray S; Fitzsimmons J; Beck B; Rao NA
Invest Ophthalmol Vis Sci; 1994 Mar; 35(3):1114-23. PubMed ID: 8125722
[TBL] [Abstract][Full Text] [Related]
7. Suppression of mitochondrial oxidative stress provides long-term neuroprotection in experimental optic neuritis.
Qi X; Lewin AS; Sun L; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2007 Feb; 48(2):681-91. PubMed ID: 17251466
[TBL] [Abstract][Full Text] [Related]
8. Loss of Nrf2 exacerbates the visual deficits and optic neuritis elicited by experimental autoimmune encephalomyelitis.
Larabee CM; Desai S; Agasing A; Georgescu C; Wren JD; Axtell RC; Plafker SM
Mol Vis; 2016; 22():1503-1513. PubMed ID: 28050123
[TBL] [Abstract][Full Text] [Related]
9. [Morphologic changes in the central nervous system of monkeys with chronic experimental allergic encephalomyelitis].
Ravkina LI; Tiufanov AV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1975; 75(7):1011-7. PubMed ID: 813465
[TBL] [Abstract][Full Text] [Related]
10. Optic neuritis in chronic relapsing experimental allergic encephalomyelitis in Biozzi ABH mice: demyelination and fast axonal transport changes in disease.
O'Neill JK; Baker D; Morris MM; Gschmeissner SE; Jenkins HG; Butt AM; Kirvell SL; Amor S
J Neuroimmunol; 1998 Mar; 82(2):210-8. PubMed ID: 9585818
[TBL] [Abstract][Full Text] [Related]
11. [Chronic experimental allergic encephalomyelitis in adult rhesus macaques].
D'iakonova IN; Ravkina LI; Matveeva TV; Kamzeev VD; Krasnova VM
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(7):40-5. PubMed ID: 7124222
[No Abstract] [Full Text] [Related]
12. Experimental allergic encephalomyelitis, a model of demyelination in central nervous system (CNS).
Gambi D; Onofrj M; Di Trapani G
Riv Neurol; 1987; 57(1):27-32. PubMed ID: 3629126
[TBL] [Abstract][Full Text] [Related]
13. Experimental allergic optic neuritis in guinea pigs: preliminary report.
Rao NA; Tso MO; Zimmerman EL
Invest Ophthalmol Vis Sci; 1977 Apr; 16(4):338-42. PubMed ID: 844991
[TBL] [Abstract][Full Text] [Related]
14. Chronologic neuropathology of relapsing experimental allergic encephalomyelitis in the mouse.
Brown A; McFarlin DE; Raine CS
Lab Invest; 1982 Feb; 46(2):171-85. PubMed ID: 7062721
[TBL] [Abstract][Full Text] [Related]
15. Axonal loss and myelin in early ON loss in postacute optic neuritis.
Klistorner A; Arvind H; Nguyen T; Garrick R; Paine M; Graham S; O'Day J; Grigg J; Billson F; Yiannikas C
Ann Neurol; 2008 Sep; 64(3):325-31. PubMed ID: 18825673
[TBL] [Abstract][Full Text] [Related]
16. Morphologic changes in chronic high-pressure experimental glaucoma in rhesus monkeys.
Hayreh SS; Pe'er J; Zimmerman MB
J Glaucoma; 1999 Feb; 8(1):56-71. PubMed ID: 10084276
[TBL] [Abstract][Full Text] [Related]
17. Differential effects of decoy chemokine (7ND) gene therapy on acute, biphasic and chronic autoimmune encephalomyelitis: implication for pathomechanisms of lesion formation.
Park IK; Hiraki K; Kohyama K; Matsumoto Y
J Neuroimmunol; 2008 Feb; 194(1-2):34-43. PubMed ID: 18155779
[TBL] [Abstract][Full Text] [Related]
18. Gene therapy with mitochondrial heat shock protein 70 suppresses visual loss and optic atrophy in experimental autoimmune encephalomyelitis.
Talla V; Porciatti V; Chiodo V; Boye SL; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2014 Jul; 55(8):5214-26. PubMed ID: 25015358
[TBL] [Abstract][Full Text] [Related]
19. The distribution of inflammatory demyelinated lesions in the central nervous system of rats with antibody-augmented demyelinating experimental allergic encephalomyelitis.
Meeson AP; Piddlesden S; Morgan BP; Reynolds R
Exp Neurol; 1994 Oct; 129(2):299-310. PubMed ID: 7525334
[TBL] [Abstract][Full Text] [Related]
20. Increase of manganese superoxide dismutase, but not of Cu/Zn-SOD, in experimental optic neuritis.
Qi X; Guy J; Nick H; Valentine J; Rao N
Invest Ophthalmol Vis Sci; 1997 May; 38(6):1203-12. PubMed ID: 9152240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
